drugset
drugset / Trial / NCT05857930

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

NCT05857930 ↗

Phase 2 Active not recruiting 296 enrolled OM Pharma SA
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing

Timeline

Start
2023-06-20
Primary completion
2026-09-30
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Broncho-Vaxom Other / unclassified 3.5 mg Oral

Indications

bronchial disorder